Capstone Triton Financial Group’s Pfizer PFE Stock Holding History

Capstone Triton Financial Group’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-34,749	Closed	-$1.27M	–	107
2023 Q2	$1.27M	Buy	34,749 +849	+3%	+$33K	0.88%	39
2023 Q1	$1.38M	Sell	33,900 -1,689	-5%	-$72.9K	1.04%	34
2022 Q4	$1.82M	Sell	35,589 -616	-2%	-$29.5K	1.46%	24
2022 Q3	$1.58M	Buy	36,205 +385	+1%	+$18.7K	1.36%	21
2022 Q2	$1.83M	Sell	35,820 -193	-0.5%	-$9.84K	1.38%	22
2022 Q1	$1.79M	Buy	+36,013	New	+$1.87M	1.25%	24
2021 Q4	–	Sell	-36,069	Closed	-$1.56M	–	114
2021 Q3	$1.56M	Buy	36,069 +914	+3%	+$40.5K	0.94%	30
2021 Q2	$1.38M	Buy	35,155 +2,328	+7%	+$90.5K	0.85%	39
2021 Q1	$1.19M	Sell	32,827 -440	-1%	-$15.6K	0.79%	39
2020 Q4	$1.23M	Buy	+33,267	New	+$1.22M	0.75%	40

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Capstone Triton Financial Group's PFE Position: Q3 2023 in Review

Capstone Triton Financial Group sold out of Pfizer (PFE) in Q3 2023, closing a stake of 34,749 shares — an estimated $1.27M sold.

Capstone Triton Financial Group first reported a position in PFE in Q4 2020 and held it in 10 quarters. The position peaked at $1.83M in Q2 2022. 2,925 funds tracked by Wall St. Rank hold PFE as of Q3 2023.

Capstone Triton Financial Group reported no remaining Pfizer position as of Q3 2023 after selling out during the quarter.
Capstone Triton Financial Group sold 34,749 Pfizer shares in Q3 2023, an estimated $1.27M.
Capstone Triton Financial Group first reported a position in Pfizer in Q4 2020 and held it in 10 quarters.
Capstone Triton Financial Group's Pfizer position peaked at $1.83M in Q2 2022.
2,925 funds tracked by Wall St. Rank held Pfizer as of Q3 2023.

Based on Capstone Triton Financial Group's 13F filing for Q3 2023, filed 11 Oct 2023.